Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Microbiology

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/JCM.41.9.4022-4030.2003PMID 12958220PMCID PMC193854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

  2003cited by this paper
• Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities

  2002cited by this paper
• The 2001 Bethesda System: terminology for reporting results of cervical cytology.

  2002cited by this paper
• Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.

  2002cited by this paper
• Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial

  2001cited by this paper
• Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

  2001cited by this paper
• Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness.

  2001cited by this paper
• Detection of high‐risk HPV types by the hybrid capture 2 test

  2001cited by this paper
• HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica

  2000cited by this paper
• Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.

  2000cited by this paper
• Human papillomavirus and cancer: the epidemiological evidence.

  2000cited by this paper
• Human papillomavirus and cancer: the epidemiological evidence

  2000cited by this paper
• HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

  2000influential reference
• Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer.

  2000cited by this paper
• Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.

  1999cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions.

  1998cited by this paper
• Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies

  1998cited by this paper
• Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening

  1996cited by this paper
• Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening

  1996cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

  1993cited by this paper
• Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

  1993influential reference
• Systematic versus random error in laboratory surveys.

  1970cited by this paper
• Systematic versus random error in laboratory surveys.

  1970cited by this paper

• Health Prognostics in Multi-sensor Systems Based on Multivariate Functional Data Analysis

  2025cites this paper
• Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation

  2023cites this paper
• Twelve-year trend in the prevalence of high-risk human papillomavirus infection among Rwandan women living with HIV.

  2020cites this paper
• Food and drug administration - approved molecular methods for detecting human papillomavirus infection.

  2019cites this paper
• Bench to Bedside - Research aspects

  2018cites this paper
• Nonparametric Bayesian covariate‐adjusted estimation of the Youden index

  2017cites this paper
• HPV Detection and Clinical Implications

  2017cites this paper
• Histopathologic follow‐up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital

  2017cites this paper
• Prevalence of High-Risk Human Papillomavirus Infection in China:  Analysis of 671,163 Human Papillomavirus Test Results From China's Largest College of American Pathologists-Certified Laboratory.

  2016cites this paper
• A model‐free estimation for the covariate‐adjusted Youden index and its associated cut‐point

  2014cites this paper
• The role of human papillomavirus infection in the head and neck region and methods for its detection.

  2014cites this paper
• Marcadores precoces de la integración del genoma viral del virus del papiloma humano: Utilidad de la detección del mRNA HPV E6/E7 en el cribado del cáncer de cérvix y en el manejo de las lesiones preinvasivas

  2014influential citation
• Human Papillomaviruses: Cervical Cancer and Warts

  2014cites this paper
• Caracterización y dinámica de los patrones de infecciones únicas y múltiples para seis tipos del virus de papiloma humano de alto riesgo

  2014cites this paper
• Factores predictores de enfermedad residual en pacientes con lesión escamosa intraepitelial de alto grado tratadas mediante conización con asa de diatermia

  2014cites this paper
• Presence of High-Risk Human Papillomavirus Genotype and Human Immunodeficiency Virus DNA in Anal High-Grade and Low-Grade Squamous Intraepithelial Lesions

  2013cites this paper
• Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

  2013cites this paper
• Molecular Tools for Detection Human Papillomavirus

  2013cites this paper
• Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis

  2013influential citation
• Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings

  2013cites this paper
• Chapter 2 Molecular Tools for Detection Human Papillomavirus

  2013influential citation
• Confidence intervals for the difference in paired Youden indices

  2013cites this paper
• Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

  2012cites this paper
• The diagnostic performance of classical molecular tests used for detecting human papillomavirus.

  2012cites this paper
• Overview on Molecular Markers to Implement Cervical Cancer Prevention: Challenges and Perspectives

  2012cites this paper
• Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results.

  2012cites this paper
• Histopathologic follow‐up and human papillomavirus DNA test results in 290 patients with high–grade squamous intraepithelial lesion papanicolaou test results

  2011cites this paper
• Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.

  2011cites this paper
• Statistical Inferences for the Youden Index

  2011cites this paper
• Correlation of histopathologic follow-up findings with vaginal human papillomavirus and low-grade squamous intraepithelial lesion Papanicolaou test results.

  2011cites this paper
• A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study

  2011influential citation
• Novel Diagnostic Methods

  2011cites this paper
• Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.

  2010cites this paper
• Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.

  2010cites this paper
• A new method of screening human papillomavirus genotypes and clinical validation.

  2010cites this paper
• High-Risk Human Papillomavirus DNA Test Results Are Useful for Disease Risk Stratification in Women With Unsatisfactory Liquid-Based Cytology Pap Test Results

  2009cites this paper
• High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.

  2009cites this paper
• Detection and Typing of Human Papillomavirus Nucleic Acids in Biological Fluids

  2009cites this paper
• Human papillomavirus genotyping using an automated film-based chip array.

  2009cites this paper
• History of cervical cancer and the role of the human papillomavirus, 1960–2000

  2009cites this paper
• Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice.

  2009cites this paper
• Nucleic Acid Based Pathogen Diagnostics

  2008cites this paper
• Adjunctive high‐risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample

  2008cites this paper
• Recovery of DNA for the detection and genotyping of human papillomavirus from clinical cervical specimens stored for up to 2 years in a universal collection medium with denaturing reagent.

  2008cites this paper
• Dismantling of the U.S. cytotechnology educational infrastructure is premature and carries significant risks.

  2008cites this paper
• Very low human papillomavirus DNA prevalence in mature women with negative computer‐imaged liquid‐based Pap tests

  2007cites this paper
• Evaluation of a Digene-recommended algorithm for human papillomavirus low-positive results present in a "retest zone".

  2007cites this paper
• Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.

  2007cites this paper
• Conserved Region Analysis of Oncogenic Human Papillomavirus Genome

  2007cites this paper
• An overview of human papillomaviruses and current vaccine strategies.

  2007cites this paper
• Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.

  2006cites this paper
• Introduction to Molecular Methodology

  2006cites this paper
• Review of Molecular Techniques for Sexually Transmitted Diseases Diagnosis

  2006cites this paper
• Prevalence of genital human papillomavirus infections established using different diagnostic techniques among males attending a urological clinic

  2006influential citation
• Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.

  2006cites this paper
• Signal Amplification Techniques: bDNA, Hybrid Capture

  2006cites this paper
• Findings From ALTS: Impact on Cervical Cytology Screening, Triage, and Patient Management

  2005cites this paper
• Management of women with cervical cytology interpreted as ASC-US or as ASC-H.

  2005cites this paper
• THE AETIOLOGY OF CERVICAL CANCER

  2005cites this paper
• Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer

  2005influential citation
• Cost‐effectiveness of liquid‐based cytology with or without hybrid‐capture II HPV test compared with conventional Pap smears: A study by the French society of clinical cytology

  2005cites this paper
• Type-Specific HPV Testing as a Predictor of High-Grade Squamous Intraepithelial Lesion Outcome after Cytologic Abnormalities

  2005cites this paper
• The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

  2005cites this paper
• Management of Women With Cervical Cytology Interpreted as ASC-US

  2005cites this paper
• Impact of Clinical Practice Guidelines on the Clinical Microbiology Laboratory

  2004cites this paper
• Hybrid Capture II and Polymerase Chain Reaction for Identifying HPV Infections in Samples Collected in a New Collection Medium

  2004cites this paper
• CORRELATION AND DISCREPANCIES BETWEEN MOLECULAR TECHNIQUES

  year unknowncites this paper